The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A, in volunteers

Anesthesia and Analgesia

Volumn 86, Issue 2, 1998, Pages 414-421

  Eger II, Edmond I ^a   Gong, Diane ^a   Koblin, Donald D ^a,b   Bowland, Terri ^a   Ionescu, Pompiliu ^a   Laster, Michael J ^a   Weiskopf, Richard B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESFLURANE; SEVOFLURANE;

ADULT; ANESTHETIC RECOVERY; ARTICLE; DRUG DEGRADATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATION ANESTHESIA; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEPHROTOXICITY; NORMAL HUMAN; PRIORITY JOURNAL; VOMITING;

ADULT; ANESTHESIA; ANESTHETICS, INHALATION; ETHERS; HUMANS; HYDROCARBONS, FLUORINATED; ISOFLURANE; MALE; METHYL ETHERS; PERCEPTION; TIME FACTORS; VOLUNTARY WORKERS;

EID: 0031936888     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199802000-00037     Document Type: Article

References (34)

1. Strum DP, Eger EI II. Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth Analg 1987;66: 654-6.
2. Yasuda N, Targ AG, Eger EI II. Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg 1989; 69:370-3.
3. Yasuda N, Lockhart SH, Eger EI II, et al. Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 1991; 72:316-24.
4. Eger EI II. Partition coefficients of I-653 in human blood, saline, and olive oil. Anesth Analg 1987;66:971-3.
5. Yasuda N, Lockhart SH, Eger EI II, et al. Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology 1991;74: 489-98.
6. Eger EI II, Bowland T, Ionescu P, et al. Recovery and kinetic characteristics of desflurane and sevoflurane in volunteers after 8-hour exposure, including kinetics of degradation products. Anesthesiology 1997;87:517-26.
7. Eger EI II, Johnson BH. Rates of awakening from anesthesia with I-653, halothane, isoflurane, and sevoflurane: a test of the effect of anesthetic concentration and duration in rats. Anesth Analg 1987;66:977-82.
8. Stoelting RK, Eger EI II. The effects of ventilation and anesthetic solubility on recovery from anesthesia: an in vivo and analog analysis before and after equilibration. Anesthesiology 1969;30: 290-6.
9. Gonsowski CT, Laster MJ, Eger EI II, et al. Toxicity of compound A in rats: effect of a 3-hour administration. Anesthesiology 1994;80:556-65.
10. Gonsowski CT, Laster MJ, Eger EI II, et al. Toxicity of compound A in rats: effect of increasing duration of administration. Anesthesiology 1994;80:566-73.
11. Keller KA, Callan C, Prokocimer P, et al. Inhalation toxicity study of a haloalkene degradant of sevoflurane, compound A (PIFE), in Sprague-Dawley rats. Anesthesiology 1995;83: 1220-32.
12. Kandel L, Laster MJ, Eger EI II, et al. Nephrotoxicity in rats undergoing a 1-hour exposure to Compound A. Anesth Analg 1995;81:559-63.
13. Eger EI II, Koblin DD, Bowland T, et al. Nephrotoxicity of sevoflurane vs. desflurane anesthesia in volunteers. Anesth Analg 1997;84:160-8.
14. Eger EI II, Gong D, Koblin DD, et al. Dose-related biochemical markers of renal injury after sevoflurane vs. desflurane anesthesia in volunteers. Anesth Analg 1997;85:1154-63.
15. Bito H, Ikeuchi Y, Ikeda K. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiology 1997;86:1231-7.
16. Kharasch ED, Frink EJ Jr, Zagar R, et al. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology 1997;86: 1238-53.
17. Tsai SK, Lee C, Kwan W-F, Chen B-J. Recovery of cognitive functions after anaesthesia with desflurane or isoflurane and nitrous oxide. Br J Anaesth 1992;69:255-8.
18. Ghouri AF, Bodner M, White PF. Recovery profile after desflurane-nitrous oxide versus isoflurane-nitrous oxide in out-patients. Anesthesiology 1991;74:419-24.
19. Tzabar Y, Asbury AJ, Millar K. Cognitive failures after general anaesthesia for day-case surgery. Br J Anaesth 1996;76:194-7.
20. Chung F, Seyone C, Dyck B, et al. Age-related cognitive recovery after general anesthesia. Anesth Analg 1990;71:217-24.
21. Welborn LG, Frazier LJ, Hannallah RS, Norden J. Comparison of emergence and recovery characteristics of sevoflurane, desflurane and halothane in pediatric patients [abstract]. Anesth Analg 1995; 80:S550.
22. Nathanson MH, Fredman B, Smith I, White PF. Sevoflurane versus desflurane for outpatient anesthesia: a comparison of maintenance and recovery profiles. Anesth Analg 1995;81: 1186-90.
23. Carpenter RL, Eger EI II, Johnson BH, et al. Pharmacokinetics of inhaled anesthetics in humans: measurements during and after the simultaneous administration of enflurane, halothane, isoflurane, methoxyflurane, and nitrous oxide. Anesth Analg 1986;65: 575-82.
24. Carpenter RL, Eger EI II, Johnson BH, et al. The extent of metabolism of inhaled anesthetics in humans. Anesthesiology 1986;65:201-5.
25. Hendrickx JFA, Soetens M, VanderDonck A, et al. Uptake of desflurane and isoflurane during closed-circuit anesthesia with spontaneous and controlled mechanical ventilation. Anesth Analg 1997;84:413-8.
26. Eger EI II. Complexities overlooked: things may not be what they seem. Anesth Analg 1997;84:239-40.
27. Jones RM, Cashman JN, Eger EI II, et al. Kinetics and potency of desflurane (I-653) in volunteers. Anesth Analg 1990;70:3-7.
28. Katoh T, Suguro Y, Nakajima R, et al. Blood concentration of sevoflurane and isoflurane on recovery from anaesthesia. Br J Anaesth 1992;69:259-62.
29. Cohen EN, Chow KL, Mathers L. Autoradiographic distribution of volatile anesthetics within the brain. Anesthesiology 1972;37: 324-31.
30. Cook TL, Smith M, Winter PM, et al. Effect of subanesthetic concentrations of enflurane and halothane on human behavior. Anesth Analg 1978;57:434-40.
31. Eger EI II. Uptake and distribution. In: Miller RD, ed. Anesthesia. New York: Churchill Livingstone, 1990:85-104.
32. Cromwell TH, Eger EI II, Stevens WC, Dolan WM. Forane uptake excretion and blood solubility in man. Anesthesiology 1971;35:401-8.
33. 2 absorbents during low-flow anesthesia in surgical patients. Anesthesiology 1992;77:1064-9.
34. Eger EI II, Ionescu P, Koblin DD, Weiskopf RB. Compound A: solubility in saline and olive oil, destruction by blood. Anesth Analg 1996;83:849-53.